Shortage Watch Free FDA drug-shortage watch

← all medications

Moxifloxacin Injection

Brand names: Moxifloxacin

Category: Anti-Infective

Not specified 1

FDA status: To Be Discontinued · Last FDA update: Oct 29, 2025 · First posted: Oct 29, 2025 · 1 manufacturers, 1 listed presentations

As of Oct 29, 2025, the FDA lists Moxifloxacin Injection as being discontinued. Of 1 manufacturer presentations, 1 Not specified.

Ask your pharmacist: which of the 1 manufacturers below can they order right now, and whether a different strength or form of Moxifloxacin Injection is available. For alternatives, talk to your prescriber — see what to do if your medication is in shortage.
Presentation & package NDCManufacturerAvailabilityFDA note
Moxifloxacin, Injection, 400mg per 250mL (NDC 63323-850-74)
NDC 63323-850-74		 Fresenius Kabi USA, LLC Not specified Discontinuation of the manufacture of the drug

Related medications in shortage

Other Anti-Infective medications currently on the FDA shortage list — useful context if you and your prescriber are weighing alternatives. Always confirm with your pharmacist.

Change log

No changes recorded yet.
Tracking began Oct 1, 2026. We check the FDA every 6 hours; any real change - a manufacturer moving from Limited to Available, a new recovery date, a new listing - shows up here with its date.

Cite this: “FDA drug-shortage status for Moxifloxacin Injection (FDA data as of Oct 29, 2025). Shortage Watch, openFDA.”

Get an email when this record changes

One email, only when the FDA changes something for Moxifloxacin Injection. You confirm by clicking a link first (double opt-in). No newsletter, no other mail.

Check your inbox - click the confirmation link to activate alerts for Moxifloxacin Injection.

Feeds instead of email: RSS or JSON. Unsubscribe anytime; see Privacy.

Embed a live status badge: /badge/moxifloxacin-injection.svg

FDA data last synced Oct 1, 2026 (FDA record dated Sep 30, 2026).